Clinical Trial Update: Pramipexole Conversion to Ropinirole Controlled Release (CR) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating switching from pramipexole to ropinirole controlled-release in Parkinson disease; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pramipexole (pramipexole)
• Ropinirole CR (ropinirole)

Snippet

Sponsor: Rajesh Pahwa, MD | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-08-24